Sight Sciences, Inc.
NASDAQ:SGHT
2.405 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 79.866 | 81.056 | 71.331 | 48.956 | 27.64 | 23.348 | 7.53 |
| Cost of Revenue
| 11.581 | 11.881 | 12.361 | 8.61 | 9.209 | 6.544 | 2.338 |
| Gross Profit
| 68.285 | 69.175 | 58.97 | 40.346 | 18.431 | 16.804 | 5.192 |
| Gross Profit Ratio
| 0.855 | 0.853 | 0.827 | 0.824 | 0.667 | 0.72 | 0.69 |
| Reseach & Development Expenses
| 17.991 | 17.556 | 22.859 | 15.634 | 8.874 | 8.124 | 5.426 |
| General & Administrative Expenses
| 0 | 106.793 | 117.465 | 74.09 | 40.945 | 30.919 | 13.063 |
| Selling & Marketing Expenses
| 0 | 2.1 | 2.6 | 2.1 | 0.8 | 1.8 | 1 |
| SG&A
| 100.826 | 108.893 | 120.065 | 76.19 | 41.745 | 32.719 | 14.063 |
| Other Expenses
| 0 | 0 | 2.225 | -6.928 | -0.071 | -0.035 | 0 |
| Operating Expenses
| 118.817 | 126.449 | 142.924 | 91.824 | 50.619 | 40.843 | 19.489 |
| Operating Income
| -50.532 | -57.274 | -83.954 | -51.478 | -32.188 | -24.039 | -14.297 |
| Operating Income Ratio
| -0.633 | -0.707 | -1.177 | -1.052 | -1.165 | -1.03 | -1.899 |
| Total Other Income Expenses Net
| -0.739 | 1.837 | -2.241 | -11.294 | -2.444 | -1.822 | 0.001 |
| Income Before Tax
| -51.271 | -55.437 | -86.195 | -62.772 | -34.632 | -25.861 | -14.296 |
| Income Before Tax Ratio
| -0.642 | -0.684 | -1.208 | -1.282 | -1.253 | -1.108 | -1.899 |
| Income Tax Expense
| 0.236 | 0.11 | 0.047 | 0.188 | 0.061 | 0.008 | -0.006 |
| Net Income
| -51.507 | -55.547 | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Net Income Ratio
| -0.645 | -0.685 | -1.209 | -1.286 | -1.255 | -1.108 | -1.898 |
| EPS
| -1.03 | -1.14 | -1.8 | -1.33 | -0.74 | -0.55 | -0.44 |
| EPS Diluted
| -1.03 | -1.14 | -1.8 | -1.33 | -0.74 | -0.55 | -0.44 |
| EBITDA
| -50.532 | -49.415 | -80.477 | -57.205 | -31.675 | -23.468 | -14.233 |
| EBITDA Ratio
| -0.633 | -0.61 | -1.146 | -1.193 | -1.146 | -1.011 | -1.89 |